News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
109last 24h
3129last 7d
511● bullish (7d)
313● bearish (7d)
227publishers
MT Newswires40d agoneutral
Summit Secures $2 Billion AstraZeneca Investment, Cancer Drug Trial CollaborationSimply Wall St.41d agoneutral
Pfizer (PFE) Heads To ESMO With 45 Oncology Abstracts And Fresh Cancer DataInvestorsHub41d agoneutral
BioNTech to Close Manufacturing Sites in Germany and Singapore After Sale Process EndsInsider Monkey42d agoneutral
Gilead’s HIV Concentration or Pfizer’s Patent Cliff: Which Risk is Easier to Own?Insider Monkey42d agoneutral
Pfizer vs. Medtronic: Which Healthcare Turnaround is More Convincing?Insider Monkey42d agoneutral
Pfizer vs. Thermo Fisher: Which Healthcare Turnaround has More Upside?Insider Monkey42d agoneutral
Pfizer (PFE) Balances Global Pricing Opportunity with New Revenue SharingMotley Fool43d agobullish
D-Wave Quantum vs. QuantumScape: Which Moonshot Tech Stock Is a Better Buy in 2026?Insider Monkey44d agoneutral
Pfizer (PFE) Targets Air Traffic Fees Over Unpaid Vaccines. Can it Turn a Court Win Into Cash?Motley Fool44d agoneutral
AbbVie vs. Pfizer: Which Healthcare Stock Makes Your Portfolio Healthier in 2026?Yahoo Finance Video44d agoneutralVIDEO
The 8:30: Trump-Xi summit takeaways, an interview with Microsoft CEO Satya NadellaSimply Wall St.45d agoneutral
What Could Pfizer (PFE) Unlock From Faster FDA Reviews And Orphan Drug Growth?Insider Monkey45d agoneutral
Could a New Vaccine Formula XFG Give Pfizer (PFE) and BioNTech (BNTX) a Post-Pandemic Revenue Boost?